资讯

“For patients seeking noticeable results, whether it's improved skin texture, better sleep, enhanced metabolism or muscle ...
FDA approves Novo Nordisk's Alhemo for hemophilia A and B without inhibitors, following strong Phase 3 results showing reduced bleeding episodes.